In their paper, MCHD also sites data that suggests use of mobile care coordination technology can help improve door-to-needle times, saying "the use of mobile technologies from Pulsara - Stop Stroke and Stop STEMI - have shown promising improvements of up to 46% in door-to-therapy times in STEMI and [Acute Ischemic Stroke (AIS)]."
Because new technologies and protocols are fast emerging in the treatment of LVO stroke patients, it is imperative that all clinicians evaluate their current systems against emerging tools to decide whether there is a need to update their processes to provide the best possible care for these extremely sensitive patients. Facilities like MCHD are leading the charge in this initiative and in so doing, continue to uphold their commitment to excellence for their patients.